Ohno Publishes in the Journal of Alzheimer’s Disease
The CDR’s PI Dr. Masuo Ohno’s review provides an overview of the utility of accelerated long-term forgetting (ALF) in a rational design of next-generation BACE1 inhibitor trials in preclinical Alzheimer’s Disease. Ohno’s review titled, “A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer’s Disease,” is published in the April edition.